XORTX Therapeutics, Inc. (XRTX)
1.70
-0.01
(-0.58%)
USD |
NASDAQ |
Sep 29, 16:00
1.58
-0.12
(-7.06%)
After-Hours: 20:00
XORTX Therapeutics Price : 1.70 for Sept. 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 28, 2026 | 1.69 | 1.741 | 1.69 | 1.71 | 30006.00 |
| Sep 25, 2026 | 1.74 | 1.82 | 1.69 | 1.69 | 46861.00 |
| Sep 24, 2026 | 1.69 | 1.78 | 1.69 | 1.72 | 51336.00 |
| Sep 23, 2026 | 1.80 | 1.830 | 1.69 | 1.70 | 59419.00 |
| Sep 22, 2026 | 1.91 | 1.93 | 1.78 | 1.86 | 79640.00 |
| Sep 21, 2026 | 1.99 | 2.09 | 1.85 | 1.95 | 227454.0 |
| Sep 18, 2026 | 1.95 | 2.65 | 1.74 | 1.92 | 7.220M |
| Sep 17, 2026 | 1.75 | 1.78 | 1.590 | 1.66 | 2.237M |
| Sep 16, 2026 | 1.85 | 1.85 | 1.765 | 1.78 | 49605.00 |
| Sep 15, 2026 | 2.05 | 2.07 | 1.81 | 1.88 | 95125.00 |
| Sep 14, 2026 | 2.02 | 2.28 | 1.940 | 2.07 | 176681.0 |
| Sep 11, 2026 | 2.41 | 2.45 | 2.17 | 2.33 | 1.917M |
| Sep 10, 2026 | 2.450 | 2.45 | 2.11 | 2.11 | 1.526M |
| Sep 09, 2026 | 2.26 | 2.31 | 2.15 | 2.158 | 14893.00 |
| Sep 08, 2026 | 2.194 | 2.38 | 2.194 | 2.28 | 9973.00 |
| Sep 04, 2026 | 2.285 | 2.45 | 2.23 | 2.31 | 14279.00 |
| Sep 03, 2026 | 2.38 | 2.38 | 2.13 | 2.15 | 2910.00 |
| Sep 02, 2026 | 2.18 | 2.48 | 2.11 | 2.48 | 5819.00 |
| Sep 01, 2026 | 2.32 | 2.32 | 2.125 | 2.16 | 14441.00 |
| Aug 31, 2026 | 2.18 | 2.34 | 2.18 | 2.32 | 5224.00 |
| Aug 28, 2026 | 2.35 | 2.437 | 2.30 | 2.338 | 24230.00 |
| Aug 27, 2026 | 2.27 | 2.64 | 2.25 | 2.44 | 32626.00 |
| Aug 26, 2026 | 2.27 | 2.377 | 2.16 | 2.218 | 1629.00 |
| Aug 25, 2026 | 1.89 | 2.39 | 1.88 | 2.26 | 41905.00 |
| Aug 24, 2026 | 2.00 | 2.00 | 1.875 | 2.00 | 1095.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Lexaria Bioscience Corp. | 3.05 |
| InMed Pharmaceuticals, Inc. | 1.395 |
| Target Group, Inc. (Canada) | 0.0005 |
| NervGen Pharma Corp. | 1.925 |
| Milestone Pharmaceuticals, Inc. | 0.8079 |
Price Related Metrics
| PEG Ratio | -0.0136 |
| Price to Book Value | 0.5345 |
| Earnings Yield | -161.4% |
| Market Cap | 2.942M |
| PEGY Ratio | -0.0136 |